UHS

Universal Health Services is deeply undervalued at 7.4x 2026E NTM earnings despite robust free cash flow and pricing power. Structural tailwinds in behavioral health, high ROIIC (15.5%), and disciplined share buybacks drive 12.1% FCFE-per-share CAGR through 2030E. Scenario analysis shows downside protection at current prices, with a base case fair value of $280.99 and a recommended accumulation limit of $217.

Universal Health Services (UHS) reported earnings 30 days ago. What's next for the stock?

KING OF PRUSSIA, Pa., Aug. 25, 2026 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) is scheduled to present at the following conferences: September 8, 2026, at 8:45am ET at the Wells Fargo Healthcare Conference September 14, 2026, at 8:30am ET at the Morgan Stanley Global Healthcare Conference September 15, 2026, at 10:15am ET at the Baird Global Healthcare Conference A live audio webcast of the presentation and a webcast replay will be available at the Investor Relations section of the Company's website (www.uhsinc.com).

UHS' 21% YTD slide has cheapened its valuation, but weaker volumes, ACA pressure and lower growth forecasts keep risks elevated.

Universal Health's $835M Talkspace acquisition expands virtual behavioral health, adding 6,000 providers and new growth opportunities.

NEW YORK--(BUSINESS WIRE)-- #HAEclassaction--UNIVERSAL HEALTH SERVICES INVESTOR ALERT: Haeggquist & Eck, LLP Investigates Universal Health Services' Directors and Officers.

Investors need to pay close attention to UHS stock based on the movements in the options market lately.

I am initiating coverage on Universal Health Services with a Buy rating and a 24-month investment horizon, citing attractive valuations. UHS's behavioral health segment offers robust EBITDA margins and geographic diversification, with growth potential from the Talkspace acquisition and UK expansion. Despite concerns from the OBBBA and recent earnings misses, UHS's strong credit profile, healthy cash flows, and low leverage support continued capital allocation flexibility.

Universal Health Services NYSE: UHS reported second-quarter adjusted earnings per share of $5.98, up 12% from a year earlier, while adjusted EBITDA less noncontrolling interests rose 5% to $678 million. The company said results benefited from a $100 million out-of-period Florida directed payment program benefit that had not been included in its original outlook.

Universal Health Services, Inc. (UHS) Q2 2026 Earnings Call Transcript